Question 1

Has Jay Peters, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $2,979 in general payments to Jay Peters, MD across 66 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Jay Peters, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Jay Peters, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
GSK	3	$1,536
Amgen	19	$338
Mylan Specialty L.p.	2	$133
AbbVie	6	$125
La Jolla Pharmaceutical Company	6	$115
Insmed, Inc.	5	$114
Merck	5	$109
Pulmonx Corporation	2	$109
Gilead	3	$59
Boehringer Ingelheim	2	$57
Shionogi Inc	2	$52
Portola Pharmaceuticals, LLC	2	$48
Actelion Pharmaceuticals US, Inc.	2	$46
United Therapeutics Corporation	1	$33
AstraZeneca	2	$31
Alcresta Therapeutics, Inc.	1	$29
Sanofi	1	$17
Genentech USA, Inc.	1	$16
Chiesi USA, Inc.	1	$15

Jay Peters, MD

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Medicare billing

Other pulmonary disease in San Antonio